122 related articles for article (PubMed ID: 16212902)
21. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.
Margalit KA; Cowan RG; Harman RM; Quirk SM
Reproduction; 2005 Nov; 130(5):751-8. PubMed ID: 16264104
[TBL] [Abstract][Full Text] [Related]
23. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
[TBL] [Abstract][Full Text] [Related]
24. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis.
Abusamra AJ; Zhong Z; Zheng X; Li M; Ichim TE; Chin JL; Min WP
Blood Cells Mol Dis; 2005; 35(2):169-73. PubMed ID: 16081306
[TBL] [Abstract][Full Text] [Related]
25. Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients.
Kotani N; Fukuo K; Yasuda O; Sugimoto K; Katuya T; Takemura Y; Kawamoto H; Yokoi T; Suzuki A; Ogihara T
Hypertens Res; 2006 Apr; 29(4):217-25. PubMed ID: 16778328
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
Alenzi FQ; Al-Ghamdi SM; Tamimi WG; Al-Sebiany AM; El-Nashar IM; El-Tounsi I; Bamaga MS; Al-Enazi MM; Al-Amri AS; Al-Sheikh IH
Yale J Biol Med; 2005 Jan; 78(1):25-36. PubMed ID: 16197727
[TBL] [Abstract][Full Text] [Related]
27. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
28. Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance.
Nolsøe RL; Hamid YH; Pociot F; Paulsen S; Andersen KM; Borch-Johnsen K; Drivsholm T; Hansen T; Pedersen O; Mandrup-Poulsen T
Genes Immun; 2006 Jun; 7(4):316-21. PubMed ID: 16691186
[TBL] [Abstract][Full Text] [Related]
29. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
[TBL] [Abstract][Full Text] [Related]
30. Suppression of the cell-mediated immune response by a Fas-immunoglobulin fusion protein.
Shen Y; Young B; Lipman ML
Transplantation; 2006 Apr; 81(7):1041-8. PubMed ID: 16612282
[TBL] [Abstract][Full Text] [Related]
31. Safrole oxide induces apoptosis by up-regulating Fas and FasL instead of integrin beta4 in A549 human lung cancer cells.
Du A; Zhao B; Miao J; Yin D; Zhang S
Bioorg Med Chem; 2006 Apr; 14(7):2438-45. PubMed ID: 16326105
[TBL] [Abstract][Full Text] [Related]
32. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
Nakano K; Saito K; Mine S; Matsushita S; Tanaka Y
Apoptosis; 2007 Jan; 12(1):45-54. PubMed ID: 17136494
[TBL] [Abstract][Full Text] [Related]
33. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
[TBL] [Abstract][Full Text] [Related]
34. [The expression and application of human Fas ligand in E.coli].
Li NL; Nie H; Yu QW; Bo J; Ma AL; Zhang JY; Shen BH; Wang L; Zhang DQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):20-2. PubMed ID: 15132896
[TBL] [Abstract][Full Text] [Related]
35. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
Dupont PJ; Warrens AN
Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
[TBL] [Abstract][Full Text] [Related]
36. Fas Ligand gene transfer enhances the survival of tissue-engineered chondrocyte allografts in mini-pigs.
Xie GH; Wang SJ; Wang Y; Zhang Y; Zhang HZ; Jin S; Wang QF; Liu ZC; Ge HL
Transpl Immunol; 2008 May; 19(2):145-51. PubMed ID: 18503890
[TBL] [Abstract][Full Text] [Related]
37. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
[TBL] [Abstract][Full Text] [Related]
38. Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.
Mohamood AS; Trujillo CJ; Zheng D; Jie C; Murillo FM; Schneck JP; Hamad AR
Int Immunol; 2006 Aug; 18(8):1265-77. PubMed ID: 16769751
[TBL] [Abstract][Full Text] [Related]
39. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
[TBL] [Abstract][Full Text] [Related]
40. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
Marín LA; Muro M; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Sanchez-Bueno F; Parrilla P; Alvarez-López MR
Tissue Antigens; 2006 Feb; 67(2):117-26. PubMed ID: 16441482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
